about
Should hormone therapy be recommended for prevention of cardiovascular disease?Progesterone for premenstrual syndromeHormone therapy in postmenopausal women and risk of endometrial hyperplasiaOral contraceptive pill as treatment for primary dysmenorrhoeaPhytoestrogens for vasomotor menopausal symptomsMicrowave therapy for cervical ectropionRecovery of bone density in women who stop using medroxyprogesterone acetateManaging the menopause.Audit of short term outcomes of surgical and medical second trimester termination of pregnancySafety of herbal medicinal products in women with breast cancer.Managing the menopause: An update.Interventions for men and women with their first episode of genital herpes.Local oestrogen for vaginal atrophy in postmenopausal women.Revised key messages for hormone replacement therapy from the New Zealand Guidelines Group.New Zealand women's experience during their first year of Jadelle® contraceptive implant.A pilot survey of the impact of menstrual cycles on adolescent health.Hormone replacement therapy comes full circle.Clinical comparison of two low-dose oral contraceptives, Minulet and Mercilon, in women over 30 years of age.Type of hormone replacement therapy and risk of venous thromboembolism.A randomized controlled trial of estrogen replacement therapy in long-term users of depot medroxyprogesterone acetate.Hormone therapy for menopausal symptoms.Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen: A cochrane review summary.Hormone therapy in postmenopausal women and risk of endometrial hyperplasia: A Cochrane review summarySteroidal contraceptives: Effect on bone fractures in womenPhytoestrogens for menopausal vasomotor symptoms: A Cochrane review summaryTrial does not change the conclusions of Cochrane review of long term hormone therapy for perimenopausal and postmenopausal womenDecision about stopping hormone replacement therapyPost abortion contraception and its effect on repeat abortions in Auckland, New ZealandReduced use of hormones and the drop in breast cancerPatients with terminal illness and their healthcare providers preferred a dosed and gradual process of truth-tellingAdvice has changed for hormone therapy in the WHI eraThe media contributed to the knowledge and decision making of patients throughout their cancer experiencesThe persistence of ritual in nursing practice [Clinical Effectiveness in Nursing 5 (4), 2001, 177–183]Spinal bone density in women using depot medroxyprogesterone contraception*1
P50
Q24187045-E6DD54EE-1060-4792-8B5D-FE8E7DB43E20Q24241153-0F0C6910-A382-42B3-A8F8-7FE6F31D37FBQ24241713-41DAB3A2-C761-4968-AEF9-60B30A639205Q24241724-1F2C5357-C39E-4F0B-82A3-5013668AB1D6Q24243494-AE40DEC2-FB1E-4606-B14C-B027F2E59948Q24243657-9664F2AE-23CB-47E0-B731-F25759350FC5Q24649062-AA386179-7F5A-4013-81E0-622941016AF2Q35742248-181511A2-1C4C-4A23-9E19-3DB031DF36C7Q37384075-19CC3F00-7274-4B44-A276-03BDAD88D417Q37720027-8C0F27CC-7E39-4F12-96D5-0109EA3CAE06Q38752834-97A43DC8-E0CB-4BF8-973D-58C65F431A89Q38941189-C713AF94-0A06-4927-B33C-1E949B304AE3Q38941662-8319F90A-9568-410A-9740-6C136F78B465Q39385861-2037F70F-3F1B-4261-94D0-BF8FCEFE7E94Q39540177-E917931F-9133-41D8-9FBC-41D4913A0000Q39901812-701B71D8-9E93-4783-9D83-5CFC1B92BDF7Q42426528-F0046FDE-ADCC-4E7D-8570-48300ADC5B2CQ42603534-C5A99F09-E09E-4817-BBC9-ABB8CCBC238CQ43245644-8F60DB27-3FBD-4652-B345-529E98D0F1A8Q44273242-0E9A49DA-9966-4911-B09B-26B66017FCFDQ53095459-D057818A-8CD1-447A-BE6E-2D53C802793CQ54568210-F9B5300F-62F5-4D75-A084-BE716E373E0AQ59619136-56787770-D0C7-4DF0-A3FE-AF54042029C7Q60315095-E2071D43-6D56-487F-9007-DF9D55299657Q60315096-77782C1E-F912-40FA-8C8F-9C8D95299024Q60315098-FDB7217C-6FD6-4804-AB9A-48A6B1DDCD10Q60315099-C4EC32D9-E3B6-45EE-8F03-0FC7605808F3Q60315100-48A54503-D227-4D3C-8053-8276AD0CF4DAQ60315104-45C6282F-E0C6-4509-ADA0-D84ED9917DEEQ60315105-B4AA8145-1C7F-4D06-BC1B-E992837020B2Q60315107-AD603A39-FB6D-4568-A6E8-67C6C7394FD7Q60315109-7CDE1304-F470-4924-BAD5-10B092F23ADEQ60315110-0949B6E0-2534-4E7B-8B85-C061B1EC8BE3Q60315115-2D8F1134-C5FA-4618-B41F-9F21CFCDAC0F
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Helen Roberts
@ast
Helen Roberts
@en
Helen Roberts
@es
Helen Roberts
@nl
Helen Roberts
@sl
type
label
Helen Roberts
@ast
Helen Roberts
@en
Helen Roberts
@es
Helen Roberts
@nl
Helen Roberts
@sl
prefLabel
Helen Roberts
@ast
Helen Roberts
@en
Helen Roberts
@es
Helen Roberts
@nl
Helen Roberts
@sl
P106
P1153
7201465252
P21
P31
P496
0000-0002-8107-5746